President & CEO, Cell Signaling Technology, Inc
Dr. Comb is interested in the communication that occurs within and between cells. In cancer, this communication is defective. By understanding the nature of the communication and the ways that it is changed in cancer, he hopes to help develop better treatments and diagnostic tools. In this interview he discusses his work on cell signaling and the development of new model systems to study cancer. He also talks about the need for young people to get involved in biomedical research.